Cite

Active Surveillance-Factors Affecting the Treatment Decision: 3M: 'Marker', 'Mapping', 'MRI'

MLA

Ender Ozden, and Mehmet Necmettin Mercimek. “Active Surveillance-Factors Affecting the Treatment Decision: 3M: ’Marker’, ’Mapping’, ‘MRI.’” Üroonkoloji Bülteni, vol. 14, June 2015, pp. 156–60. EBSCOhost, https://doi.org/10.4274/uob.379.



APA

Ender Ozden, & Mehmet Necmettin Mercimek. (2015). Active Surveillance-Factors Affecting the Treatment Decision: 3M: ’Marker’, ’Mapping’, “MRI.” Üroonkoloji Bülteni, 14, 156–160. https://doi.org/10.4274/uob.379



Chicago

Ender Ozden, and Mehmet Necmettin Mercimek. 2015. “Active Surveillance-Factors Affecting the Treatment Decision: 3M: ’Marker’, ’Mapping’, ‘MRI.’” Üroonkoloji Bülteni 14 (June): 156–60. doi:10.4274/uob.379.